Press releases
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24 Apr 24
News, Press Releases
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
15 Apr 24
Press Releases
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
9 Apr 24
Health Care, Press Releases
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
5 Apr 24
News, Management, Press Releases
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
6 Mar 24
News, Press Releases
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
5 Mar 24
Earnings, Press Releases
Cutaneous Melanoma Market Size in 7MM is Anticipated to See a Significant Change by 2032
12 Feb 24
News, Press Releases